Get the Stockscreener App
11.04
1.16%
-0.13
After Hours:
11.06
0.02
+0.18%
Kura Oncology Inc Stock (KURA) Latest News
Kura Oncology price target raised to $37 from $32 at H.C. Wainwright - MSN
How to Take Advantage of moves in (KURA) - Stock Traders Daily
Kura Oncology's SWOT analysis: precision cancer drug stock faces pivotal year - Investing.com India
Kura, Kyowa Kirin to co-develop ziftomenib in $1.49B deal - BioWorld Online
Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit - The Manila Times
Jefferies Financial Group Issues Pessimistic Forecast for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World
Kura Oncology (NASDAQ:KURA) Given Buy Rating at TD Cowen - Defense World
FY2025 EPS Estimate for Kura Oncology Raised by Analyst - Defense World
Kura Oncology (NASDAQ:KURA) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
Brokers Offer Predictions for Kura Oncology FY2025 Earnings - MarketBeat
Leerink Partnrs Predicts Stronger Earnings for Kura Oncology - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript - MSN
Bank of America Issues Pessimistic Forecast for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World
Kura Oncology partners Kyowa Kirin to advance AML treatment - MSN
Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover - MSN
Kura Oncology (NASDAQ:KURA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Kura Oncology & Kyowa Kirin ink billion dollar deal to develop and commercialise Ziftomenib for acute leukemia treatment - BSA bureau
Stifel cuts Kura Oncology target to $11 from $18, holds rating - Investing.com Canada
Firm Advises Kura Oncology on Global Strategic Collaboration with Kyowa Kirin - Wilson Sonsini
10 Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Kura Oncology Stock Slips Following Collaboration With Kyowa: Retail Turns Extremely Bullish - MSN
Kura Oncology (NASDAQ:KURA) Given New $29.00 Price Target at Bank of America - MarketBeat
Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 By Investing.com - Investing.com South Africa
Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 - Investing.com India
Kura Oncology inks global deal with Kyowa Kirin By Investing.com - Investing.com Nigeria
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin - MedCity News
Stock market news: Perspective Therapeutics -44.33%, Pyxis Oncology -42.93% among top losers during mid day trading - Business Upturn
Kura Oncology: A Contender In The Field Of Precision Medicine - Seeking Alpha
Kura Oncology shares hold Buy rating after Kyowa Kirin deal By Investing.com - Investing.com Canada
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings - Benzinga
Stock market today: Pyxis Oncology plunges by 47.25% while Perspective Therapeutics declines by 46.68% in early trading - Business Upturn
Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn
Kura Oncology tumbles as Kyowa collaboration seen hitting M&A prospects By Investing.com - Investing.com Canada
Buy rating reiterated for Kura Oncology stock, analyst raises target on ziftomenib advancements - Investing.com Canada
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26% - Yahoo! Voices
Biotech Collapses 27% After Slamming The Door On A Takeover - Investor's Business Daily
HC Wainwright Forecasts Strong Price Appreciation for Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax - BioSpace
Kura Oncology inks global deal with Kyowa Kirin - Investing.com
Kura and Kyowa Kirin sign ziftomenib deal - The Pharma Letter
Kura partners with Kyowa Kirin to advance AML treatment - Pharmaceutical Technology
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - Barchart
Kura Oncology stock gains momentum as Jefferies sees potential menin leadership - Investing.com UK
Kura stock slides 17% on Kyowa Kirin deal for ziftomenib - MSN
Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration - MarketWatch
KURAKura Oncology, Inc. Latest Stock News & Market Updates - StockTitan
Kura Oncology to partner with Kyowa Kirin for blood cancer therapy - Reuters
Kura Oncology (NASDAQ:KURA) Cut to Sell at StockNews.com - MarketBeat
Kura Oncology's (KURA) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):